Interestingly, our study provides the first evidence that Mon treatment could ameliorate the elevated levels of HMGB1 and TLR4 in diabetic rats underscoring the potential renoprotective effect of the Mon via decreasing inflammation in DN. The gene discussed is HMGB1; the disease is liver dysplastic nodule.